Form 8-K - Current report:
SEC Accession No. 0001213900-25-008463
Filing Date
2025-01-30
Accepted
2025-01-30 17:30:25
Documents
27
Period of Report
2025-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0229310-8k_60degrees.htm   iXBRL 8-K 57420
2 ENGAGEMENT AGREEMENT ea022931001ex1-1_60degrees.htm EX-1.1 55159
3 AMENDMENT TO ENGAGEMENT AGREEMENT ea022931001ex1-2_60degrees.htm EX-1.2 12731
4 EXTENSION TO ENGAGEMENT AGREEMENT ea022931001ex1-3_60degrees.htm EX-1.3 12694
5 FORM OF WARRANT ea022931001ex4-1_60degrees.htm EX-4.1 96070
6 FORM OF PLACEMENT AGENT WARRANT ea022931001ex4-2_60degrees.htm EX-4.2 95183
7 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea022931001ex5-1_60degrees.htm EX-5.1 10818
8 FORM OF SECURITIES PURCHASE AGREEMENT ea022931001ex10-1_60degrees.htm EX-10.1 253686
9 PRESS RELEASE, DATED JANUARY 29, 2025 ea022931001ex99-1_60degrees.htm EX-99.1 13119
10 PRESS RELEASE, DATED JANUARY 30, 2025 ea022931001ex99-2_60degrees.htm EX-99.2 13579
11 GRAPHIC ex5-1_001.jpg GRAPHIC 24122
16 GRAPHIC ex1-1_001.jpg GRAPHIC 25431
17 GRAPHIC ex1-2_001.jpg GRAPHIC 25431
18 GRAPHIC ex1-3_001.jpg GRAPHIC 25575
  Complete submission text file 0001213900-25-008463.txt   1137453

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE sxtp-20250128.xsd EX-101.SCH 3813
13 XBRL DEFINITION FILE sxtp-20250128_def.xml EX-101.DEF 26668
14 XBRL LABEL FILE sxtp-20250128_lab.xml EX-101.LAB 36762
15 XBRL PRESENTATION FILE sxtp-20250128_pre.xml EX-101.PRE 25292
30 EXTRACTED XBRL INSTANCE DOCUMENT ea0229310-8k_60degrees_htm.xml XML 5801
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 25575011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)